Incorrect artwork version used during packaging operations – CAPA ineffectiveness analysis


Published on 08/01/2026

Case Study on Incorrect Artwork Version in Packaging Operations and Its CAPA Analysis

The pharmaceutical industry is increasingly challenged by operational deviations that can compromise adherence to Good Manufacturing Practices (GMP). One such case involved the use of an incorrect artwork version during packaging operations, which raised concerns about data integrity and regulatory compliance. This article analyzes the scenario, detailing the detection, containment, investigation, corrective and preventive actions taken, and insights gained that can be applied to avoid future occurrences.

If you want a complete overview with practical prevention steps, see this Packaging & Labeling Deviations.

By the conclusion of this comprehensive case study, readers will be equipped with a structured approach to manage similar deviations involving artwork discrepancies and ensure compliance with regulatory requirements set by FDA, EMA, and MHRA. A series of actionable steps and decision points will be unveiled, fostering an environment conducive to continuous improvement in packaging and labeling processes.

Symptoms/Signals on the Floor or in the

Lab

In our case study, the first signs of the problem emerged during the finished product quality control review. During routine checks, the Quality Control (QC) team identified that the packaging used for a newly released product displayed discrepancies when compared to the marketing-approved artwork. The following symptoms were observed:

  • Label Mismatch: The revision of the artwork approved for printing was not the one executed during the packaging process.
  • Documentation Errors: Batch records indicated the version of the artwork used did not match the master records.
  • Surge in Customer Complaints: Initial customer feedback signaled confusion over product indications due to the incorrect artwork.

Noticing these anomalies, immediate steps were undertaken to contain the situation. For investigation purposes, logs detailing the batch release, approval processes, and inventory were scrutinized. This initiative highlighted potential failures within document control systems and quality assurance checks that must be addressed.

Likely Causes

Upon preliminary analysis, several categories of failure modes were identified that contributed to the use of the incorrect artwork during packaging operations. The classification of causes is as follows:

Category Likely Cause
Materials Incorrect label stock received from supplier.
Method Inadequate procedure for verifying artwork against approval requirements.
Machine Software glitch in labeling printer not flagging discrepancies.
Man Human error in selecting the version of artwork for production.
Measurement Insufficient checking mechanisms to verify labels against master records.
Environment Poor training on document control processes among staff.

This categorization will assist in the identification of critical failure points for subsequent investigation phases.

Immediate Containment Actions

Within the first 60 minutes of detection, the following containment actions were implemented:

  • Halt Packaging Operations: All packaging activities were suspended to prevent additional discrepancies.
  • Alert Quality Assurance: QA was immediately notified to launch an investigation into the matter.
  • Inventory Hold: All impacted batches were placed on hold pending an investigation and review.
  • Communication: A notice was sent to relevant departments to ensure awareness of the issue and its potential impact.

These measures were essential to mitigate risks associated with patient safety, product efficacy, and regulatory compliance.

Investigation Workflow

The investigation process involved a structured approach in data collection, as follows:

  • Document Review: All pertinent documents, including batch records, approval documents, and packaging logs, were collected for review.
  • Interviews: Staff involved in the artwork approval and packaging processes were interviewed to gather insights on procedural adherence and any lapses.
  • Traceability Analysis: A traceability analysis was employed to verify the flow of information from artwork approval to packaging execution.

Throughout the investigation, close attention was paid to interpreting data to ascertain where and why deviations occurred, as well as identifying lapses in communication and documentation practices.

Root Cause Tools

In deploying root cause analysis techniques, we utilized three effective tools:

  • 5-Why Analysis: Focused on drilling down to the fundamental cause by repeatedly asking ‘why’ the incorrect artwork was used. This process revealed a lack of verification protocols.
  • Fishbone Diagram: Utilized for organizing potential causes into categories, highlighting lack of training as a key contributor.
  • Fault Tree Analysis: Implemented to map out the sequence of events leading to the artwork error, illustrating multiple potential failure points that occurred in tandem.

Choosing the right tool depends on the complexity of the issue. In this case, the combination of 5-Why and Fishbone provided a comprehensive perspective on operational flaws.

CAPA Strategy

The Corrective and Preventive Action (CAPA) strategy was systematically developed as follows:

  • Correction: Immediate correction involved reprinting the artwork for stock already packaged to eliminate inconsistences.
  • Corrective Action: Enhancements to the approval process for artwork, including implementation of a dual-check system where two employees independently verify the final version before printing.
  • Preventive Action: Regular training sessions on the importance of following established protocols and documentation verification processes to ensure systemic adherence.

This holistic CAPA approach ensures ongoing compliance and minimizes the risk of recurrence.

Related Reads

Control Strategy & Monitoring

To effectively monitor compliance and controls after implementation of corrective actions, a robust control strategy was established:

  • Statistical Process Control (SPC): Implementation of SPC measures to track manufacturing process variations.
  • Regular Sampling: More frequent sampling of packaged goods alongside labeling verification against approved documents.
  • Alert Mechanisms: Incorporation of alert systems within the packaging equipment to flag errors when discrepancies in artwork versions are detected.

By prioritizing monitoring, organizations can maintain visibility into ongoing compliance and effectiveness of their control measures.

Validation / Re-qualification / Change Control Impact

Due to the deviation’s nature, validation and change control processes required careful scrutiny. The following considerations were involved:

  • Validation Re-assessment: Given the changes to packaging processes, a re-assessment of validation was essential to ensure that the new procedures align with regulatory standards.
  • Impact on Change Control: Complete documentation of the deviation led to updating the Change Control documents, requiring formal approval for any updates in the artwork approval process.
  • Risk Assessment: Conducted a thorough risk assessment to identify how these changes could impact product quality and safety.

By effectively managing validation and change control requirements, the organization safeguarded its products against future deviations.

Inspection Readiness: What Evidence to Show

Preparation for regulatory inspections demands meticulous documentation. Evidence to demonstrate compliance included:

  • Batch Records: Thoroughly maintained batch records must show detailed logs of the artwork used for each production run alongside deviation documentation.
  • CAPA Documentation: Comprehensive records of the investigation, corrective measures implemented, and preventive measures established.
  • Training Records: Documentation of training conducted for personnel involved in packaging and artwork approval.
  • Audit Logs: Detailed logs that track personnel actions and materials used during packaging operations to ensure full traceability.

This evidence establishes a clear framework for demonstrating GMP compliance and paving the way for successful regulatory audits.

FAQs

What is the importance of artwork verification in pharmaceutical packaging?

Artwork verification is crucial in ensuring labeling accuracy, thereby preventing misinformation and ensuring patient safety.

What tools can be utilized for root cause analysis?

Common tools include 5-Why analysis, Fishbone diagrams, and Fault Tree analysis, each serving different analytical needs.

How can immediate containment actions prevent issues from escalating?

Immediate actions help to limit exposure to the deviation, preserving product integrity and minimizing potential regulatory ramifications.

Why is CAPA vital in deviation management?

CAPA is essential for addressing and preventing reoccurrence of deviations, ensuring continuous improvement in quality systems.

What should be documented during a deviation investigation?

Documentation should include investigative findings, corrective and preventive actions, and the rationale for decisions made throughout the investigation.

How frequently should training on quality processes be conducted?

Training should be ongoing, with regular sessions that reinforce compliance and update staff on changes in regulations and processes.

What role does risk assessment play in managing packaging deviations?

Risk assessment identifies potential impacts of deviations, guiding corrective actions and enhancing decision-making processes.

How can organizations ensure they remain inspection-ready?

Having organized, up-to-date documentation and a culture of compliance among staff ensures that organizations are always prepared for inspections.

Pharma Tip:  Label reconciliation failure during packaging operations – recall risk case study